» Articles » PMID: 31147276

Incorporating Patient Input into the Design of a Disease Management Program for COPD

Overview
Journal Healthc (Amst)
Publisher Elsevier
Specialty Health Services
Date 2019 Jun 1
PMID 31147276
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

In the era of value-based payment contracts, there is increasing emphasis on disease management as a strategy for improving care quality and reducing costs. To design effective disease management programs, healthcare systems should understand the day-to-day experience of living with particular health conditions, and ensure that evidence-based services and interventions are adapted to align with the realities of patients' lives and their priorities. For healthcare systems operating with limited resources, there is a need for practical and small-scale approaches for collecting and using patient input as part of program design and operations. This case study describes a targeted interview process that Cambridge Health Alliance (CHA) used to gather patient input during the design of a disease management program for chronic obstructive pulmonary disease. The patient perspectives gathered through the interviews influenced several aspects of the program design. The key lessons from CHA's experience are: 1) A small-scale approach with cycles of 5-10 interviews can produce valuable insights for program design; 2) Short patient vignettes can be used to summarize patient data in a simple and compelling format; and 3) Clinicians' perspectives are critical for interpreting patient input and extracting information that is most likely to be useful for program design. CHA's approach provides an example of a systematic and practical process for gathering patient input that other healthcare systems can adapt to their local contexts.

Citing Articles

Information overload, financial constraints, and psychological burdens are among the barriers faced by marginalized groups seeking curative treatments for HCC.

Nephew L, Moore C, Garcia N, Parks L, McKay A, Strauss A Hepatol Commun. 2025; 9(3).

PMID: 40008878 PMC: 11868430. DOI: 10.1097/HC9.0000000000000660.


Ensuring equity with pre-clinical planning for chlamydia vaccines.

Collar A, Clarke T, Jamus A, Frietze K NPJ Vaccines. 2023; 8(1):131.

PMID: 37673890 PMC: 10482967. DOI: 10.1038/s41541-023-00726-7.